Respiratory infections in patients receiving Immune Checkpoint Inhibitors using the World Health Organization pharmacovigilance database- VigiBase

被引：0
|
作者：
Maitre, Thomas [1 ]
Ferry, Virginie
Bihan, Kevin [2 ]
Canellas, Anthony [1 ]
Godet, Cendrine [1 ]
Cadranel, Jacques [1 ]
机构：
[1] Hop Tenon, APHP, Pneumol, Paris, France
[2] Sorbonne Univ, Dept Pharmacol, Pitie Salpetriere Hosp, AP HP,Reg Pharmacovigilance Ctr,INSERM, Paris, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA3298
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Myositis associated with Immune Checkpoint Inhibitors: A pharmacovigilance study using the World Health Organization's adverse drug reactions database
    Ladhari, C.
    Nguyen, T.
    Maria, A.
    Palassin, P.
    Quantin, X.
    Lesage, C.
    Taieb, G.
    Ayrignac, X.
    Rullier, P.
    Lambotte, O.
    Guilpain, P.
    Hillaire-Buys, D.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 103 - 103
  • [2] Infections in patients receiving immune checkpoint inhibitors.
    Sae-Tia, Sutthichai
    Naidoo, Jarushka
    Mehta, Seema
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [3] Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase
    Roselli, Audrey
    Khouri, Charles
    Roustit, Matthieu
    Blaise, Sophie
    Cracowski, Jean-Luc
    DERMATOLOGIC SURGERY, 2019, 45 (12) : 1517 - 1528
  • [4] Safety profile of sclerosing agents: an analysis from the world health organization pharmacovigilance database VigiBase®
    Khouri, C.
    Roselli, A.
    Roustit, M.
    Blaise, S.
    Cracowski, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 53 - 53
  • [5] Immune checkpoint inhibitor-associated myasthenia: a world health organization VigiBase® analysis
    Rouby, F.
    Laugier, D.
    Lacroix, C.
    Default, A.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 72 - 73
  • [6] Immune Checkpoint Inhibitors-induced transplant rejection: Analysis of the world pharmacovigilance database
    Gerard, A.
    Merino, D.
    Cremoni, M.
    Borchiellini, D.
    Rocher, F.
    Esnault, V. L. M.
    Sicard, A.
    Drici, M. D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 109 - 109
  • [7] Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase)
    Henry, Alexandra
    Santulli, Pietro
    Bourdon, Mathilde
    Maignien, Chloe
    Chapron, Charles
    Treluyer, Jean-Marc
    Guibourdenche, Jean
    Chouchana, Laurent
    HUMAN REPRODUCTION OPEN, 2025, 2025 (01)
  • [8] PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase
    Park, Dahyun
    Bea, Sungho
    Bae, Ji-Hwan
    Lee, Hyesung
    Choe, Young June
    Shin, Ju-Young
    Kim, Hoon
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (03) : 465 - 475
  • [9] Autoimmune Hematological Toxicities of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Database Analysis
    Keerty, Dinesh
    Haddad, Philip A.
    Ramadas, Poornima
    Master, Samip R.
    BLOOD, 2022, 140 : 13160 - 13161
  • [10] Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®)
    Batteux, B.
    Bennis, Y.
    Bodeau, S.
    Masmoudi, K.
    Hurtel-Lemaire, A. S.
    Kamel, S.
    Gras-Champel, V.
    Liabeuf, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 159 - 159
12345